Bauer Jake 4
4 · Enliven Therapeutics, Inc. · Filed Apr 6, 2023
Insider Transaction Report
Form 4
Bauer Jake
Director
Transactions
- Award
Stock Option (right to buy)
2023-02-23+27,567→ 27,567 totalExercise: $25.28Exp: 2033-02-23→ Common Stock (27,567 underlying)
Footnotes (1)
- [F1]1/36th of the shares subject to the option will vest on March 23, 2023 and each month thereafter, subject to the Reporting Person continuing as a service provider through each such date.